Phase III, Study of Three Short Course Combination Regimens (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome® Alone for the Treatment of Visceral Leishmaniasis in Bangladesh
This study is currently recruiting participants.
Verified July 2011 by Drugs for Neglected Diseases
Sponsor:
Drugs for Neglected Diseases
Collaborators:
Shaheed Surhawardy Medical College and Hospital
International Centre for Diarrhoeal Disease Research, Bangladesh
Information provided by:
Drugs for Neglected Diseases
ClinicalTrials.gov Identifier:
NCT01122771
First received: May 11, 2010
Last updated: July 1, 2011
Last verified: July 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | July 2012 |
| Estimated Primary Completion Date: | December 2011 (Final data collection date for primary outcome measure) |